oldjoe1
23 Mar 2015
SN.Broker UPGRADE........... Smith & Nephew has been raised to 'buy' from 'neutral' at Goldman Sachs on Monday due to improving fundamentals and under-appreciated strategic value.Goldman also increased its target price on the stock, up to 1300p from 1200p.The bank said Smith & Nephew's stock has been a notable under-performer despite solid FY14 results, with sentiment driven largely by questions on whether the company is still a likely acquisition target."We continue to believe that further consolidation in orthopaedics - with Smith & Nephew being acquired by a larger player - makes strategic sense, though recognise the multiple hurdles to a potential transaction," said Goldman.The bank expects 2015 to mark an important turning point for the company. "We expect organic top-line growth to re-accelerate to around 5% per year versus the 2009-14 average of below 3% as Smith & Nephew benefits from ongoing utilisation recovery in the US, and addresses some of the recent causes of underperformance in the wound business," said Goldman.It added that it also sees meaningful opportunities for margin expansion "driven by integration of Arthrocare and the $120m efficiency program announced in 2014.
oldjoe1
06 Mar 2015
SN. Broker Views.... SN. Broker views.....04 Mar Exane BNP Paribas Outperform 1,148.50 1,325.00 1,325.00 Reiterates04 Mar Deutsche Bank Buy 1,148.50 1,250.00 1,250.00 Reiterates02 Mar Numis Hold 1,148.50 - 1,105.00 Reiterates
LK Hyman
05 Mar 2015
Re: The Dark Destroyer tips SN. Oldjoe,"a bid could be imminent."Perhaps J&J could come in for S&N now that they appear to have been pipped at the post by AbbVie for Pharmacyclics?I don't think I buy the Stryker "it's just a feint to get the S&N price down" story about the rationale for their extended buy-back thingy.It does seem likely that, at some stage, S&N could be a tasty morsel for someone, so I'm happy to keep holding.LKH on the flybridge
oldjoe1
05 Mar 2015
The Dark Destroyer tips SN. <b>Interesting to see Matt Earl (The Dark Destroyer)as gone long on the stock here. hes the chap who alerted everyone to his TUNG short and as a fantastic record.</b>Taken from his Blog.Heres what he says........<b>.Wednesday, 4 March 2015Smith & Nephew (SN/) ... coldwater morning</b>I've bought a wodge of Smith & Nephew (SN/ LN) at 1140p/shr and an 1100 put.Yesterday's move by Stryker (SYK US), in announcing a $2 billion extension to its authorised buy back scheme, seems to me to be a mere attempt to pour cold water over S&N's potential purchase price. And so I reckon that suggests a bid could be imminent. North of 1350p/shr would be satisfactory.[link] doubt we will hear more from Matt.
oldjoe1
05 Mar 2015
SN. Broker Update..... <b>Smith & Nephew plc Stock Rating Reaffirmed by Sanford C. Bernstein (SN)</b>March 3rd, 2015 Updated 5th March 2015Smith & Nephew plc (LON:SN)‘s stock had its “outperform” rating restated by investment analysts at Sanford C. Bernstein in a note issued to investors on Tuesday. They currently have a GBX 1,350 ($20.80) target price on the stock. Sanford C. Bernstein’s target price would suggest a potential upside of 12.68% from the company’s current price.Shares of Smith & Nephew plc (LON:SN) traded down 5.34% during mid-day trading on Tuesday, hitting GBX 1135.00. The stock had a trading volume of 11,677,271 shares. Smith & Nephew plc has a one year low of GBX 858.50 and a one year high of GBX 1211.00. The stock’s 50-day moving average is GBX 1180. and its 200-day moving average is GBX 1093.. The company’s market cap is £10.136 billion.Several other analysts have also recently commented on the stock. Analysts at Numis Securities Ltd reiterated a “hold” rating and set a GBX 1,105 ($17.03) price target on shares of Smith & Nephew plc in a research note on Monday. Analysts at AlphaValue reiterated a “buy” rating and set a GBX 1,399 ($21.56) price target on shares of Smith & Nephew plc in a research note on Friday. Analysts at Cenkos Securities Ltd reiterated a “buy” rating and set a GBX 1,200 ($18.49) price target on shares of Smith & Nephew plc in a research note on Thursday, February 12th. Finally, analysts at Berenberg Bank raised their price target on shares of Smith & Nephew plc from GBX 990 ($15.26) to GBX 1,080 ($16.64) and gave the company a “hold” rating in a research note on Monday, February 9th. Three research analysts have rated the stock with a sell rating, ten have issued a hold rating and eight have given a buy rating to the company’s stock. The stock presently has an average rating of “Hold” and an average target price of GBX 1,107.59 ($17.07).Smith & Nephew plc is a global medical devices business operating in the markets for orthopaedic reconstruction and trauma, endoscopy (LON:SN) and advanced wound management. It operates in three segments: Orthopaedics, Endoscopy and Advanced Wound Management.
walrusty
03 Mar 2015
Shock reaction Hope lead is replaced by helium balloon shortly.
nk1999
02 Feb 2015
Times "Buy shares of Smith & Nephew, Danny Fortson advised in the Sunday Times. The Inside the City columnist said shares of the maker of artificial hips and knees had surged after US rival Stryker said it was considering a bid. Smith & Nephew releases annual results on February 5th and the numbers are likely to be good. The possible Stryker deal is the most important question. A deal would be logical because US hospitals and insurers want suppliers to cut prices. Scale would help and there will be no shortage of demand."SP before publication 1191.nk
II Editor
05 Jan 2015
NEW ARTICLE: Why Now Is A Great Opportunity To Take Profit On Takeover Target Smith & Nephew plc "Smith & Nephew (LSE:SN) (NYSE: SNN.US) is on a roll. If you are invested and you are perhaps tempted to cash in now, you may well be right. Here's why. Performance/PremiumS&N shares have risen 7% since 23 December, when it was rumoured once ..."[link]
II Editor
24 Dec 2014
NEW ARTICLE: Why Smith & Nephew plc Is Attracting Interest From Stryker Corporation "Shares in medical equipment manufacturer Smith & Nephew (LSE:SN) have exploded in pre-Christmas trading as speculation over a potential takeover by American group Stryker reaches fever pitch.The London-based company is currently up around 8% at ..."[link]
frog in a tree
24 Dec 2014
Re: Takeover imminent? See [link]
LK Hyman
24 Dec 2014
Re: Takeover imminent? Aspace,"Any views, or news I may have missed, on likelihood of takeover/merger would be appreciated."Is Stryker homing in on the target? This is a little more than the usual blip, ain't it?[link] at the LK Wash & Valet Happy Christmas one and all
Martin John13
24 Nov 2014
Stryker Bid Speculation mounts again about a possible Stryker offer for Smith & Nephew now that a 6-month no-bid period has ended.
